LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News
Investing Articles
2 FTSE 100 growth stocks to buy before it’s too late?
Investing Articles
These FTSE 100 stocks rocketed 20% in February. Can they keep going?
Investing Articles
Why this growth stock could soar 40%+ within 2 years